AMRN Stock Summary and Trading Ideas (Amarin PLC - American Depositary Shares | NASDAQ:AMRN)

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Amarin PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol AMRN.

As of January 13, 2026, AMRN stock price declined to $15.30 with 17,429 million shares trading.

AMRN has a beta of 1.79, meaning it tends to be more sensitive to market movements. AMRN has a correlation of 0.25 to the broad based SPY ETF.

AMRN has a market cap of $318.13 million. This is considered a Small Cap stock.

Last quarter Amarin PLC - American Depositary Shares reported $50 million in Revenue and $.19 earnings per share. This beat revenue expectation by $7 million and exceeded earnings estimates by $.22.

In the last 3 years, AMRN traded as high as $44.60 and as low as $7.08.

The top ETF exchange traded funds that AMRN belongs to (by Net Assets): SPDW, GWX.

AMRN has outperformed the market in the last year with a price return of +38.6% while the SPY ETF gained +21.0%. However, in the short term, AMRN had mixed performance relative to the market. It has underperformed in the last 3 months, returning -16.1% vs +6.7% return in SPY. But in the last 2 weeks, AMRN shares have fared better than the market returning +9.0% compared to SPY +1.0%.

AMRN support price is $14.97 and resistance is $16.15 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AMRN shares will trade within this expected range on the day.